
PubMed:25056937
Annnotations
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 103-109 | HP_0002664 | denotes | Cancer |
T2 | 442-448 | HP_0002664 | denotes | cancer |
T3 | 656-671 | HP_0012125 | denotes | prostate cancer |
T4 | 665-671 | HP_0002664 | denotes | cancer |
T5 | 836-841 | HP_0002664 | denotes | tumor |
T6 | 1150-1160 | HP_0000718 | denotes | aggressive |
T7 | 1181-1187 | HP_0002664 | denotes | cancer |
T8 | 1435-1450 | HP_0012125 | denotes | prostate cancer |
T9 | 1444-1450 | HP_0002664 | denotes | cancer |
T10 | 1974-1980 | HP_0002664 | denotes | cancer |
T11 | 2134-2153 | HP_0012125 | denotes | cancer of prostatic |
T12 | 2134-2140 | HP_0002664 | denotes | cancer |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
25056937-0#26#48#gene1803 | 26-48 | gene1803 | denotes | dipeptidyl peptidase 4 |
25056937-0#75#101#diseaseC0936223 | 75-101 | diseaseC0936223 | denotes | metastatic prostate cancer |
25056937-0#75#101#diseaseC1282496 | 75-101 | diseaseC1282496 | denotes | metastatic prostate cancer |
25056937-12#58#62#gene1803 | 2047-2051 | gene1803 | denotes | DPP4 |
25056937-12#134#151#diseaseC0027627 | 2123-2140 | diseaseC0027627 | denotes | metastatic cancer |
25056937-12#134#151#diseaseC0346957 | 2123-2140 | diseaseC0346957 | denotes | metastatic cancer |
26#48#gene180375#101#diseaseC0936223 | 25056937-0#26#48#gene1803 | 25056937-0#75#101#diseaseC0936223 | associated_with | dipeptidyl peptidase 4,metastatic prostate cancer |
26#48#gene180375#101#diseaseC1282496 | 25056937-0#26#48#gene1803 | 25056937-0#75#101#diseaseC1282496 | associated_with | dipeptidyl peptidase 4,metastatic prostate cancer |
58#62#gene1803134#151#diseaseC0027627 | 25056937-12#58#62#gene1803 | 25056937-12#134#151#diseaseC0027627 | associated_with | DPP4,metastatic cancer |
58#62#gene1803134#151#diseaseC0346957 | 25056937-12#58#62#gene1803 | 25056937-12#134#151#diseaseC0346957 | associated_with | DPP4,metastatic cancer |
DisGeNet-2017-sample
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1996 | 26-48 | gene:1803 | denotes | dipeptidyl peptidase 4 |
T1997 | 75-101 | disease:C0936223 | denotes | metastatic prostate cancer |
R1 | T1996 | T1997 | associated_with | dipeptidyl peptidase 4,metastatic prostate cancer |
R2 | T1996 | T1997 | associated_with | dipeptidyl peptidase 4,metastatic prostate cancer |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-102 | Sentence | denotes | Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. |
TextSentencer_T2 | 103-190 | Sentence | denotes | Cancer is responsible for many deaths and is a major source of healthcare expenditures. |
TextSentencer_T3 | 191-340 | Sentence | denotes | The identification of new, non-invasive biomarkers might allow improvement of the direct diagnostic or prognostic ability of already available tools. |
TextSentencer_T4 | 341-598 | Sentence | denotes | Here, we took the innovative approach of interrogating the activity of exopeptidases in the serum of cancer patients with the aim of establishing a distinction based on enzymatic function, instead of simple protein levels, as a means to biomarker discovery. |
TextSentencer_T5 | 599-854 | Sentence | denotes | We first analyzed two well-characterized mouse models of prostate cancer, each with a distinct genetic lesion, and established that broad exopeptidase and targeted aminopeptidase activity tests reveal proteolytic changes associated with tumor development. |
TextSentencer_T6 | 855-1084 | Sentence | denotes | We also describe new peptide-based freeze-frame reagents uniquely suited to probe the altered balance of selected aminopeptidases, as opposed to the full array of exopeptidases, and/or their modulators in patient serum or plasma. |
TextSentencer_T7 | 1085-1205 | Sentence | denotes | One particular proteolytic activity was impaired in animals with aggressive disease relative to cancer-free littermates. |
TextSentencer_T8 | 1206-1363 | Sentence | denotes | We identified the protease in question as dipeptidyl peptidase 4 (DPP4) by analyzing selected knockout mice and evaluating the effect of specific inhibitors. |
TextSentencer_T9 | 1364-1515 | Sentence | denotes | DPP4 activity was also reduced in the sera of patients with metastatic prostate cancer relative to patients with localized disease or healthy controls. |
TextSentencer_T10 | 1516-1672 | Sentence | denotes | However, no significant differences in DPP4 serum levels were observed, which established the loss of activity as the result of impaired enzymatic function. |
TextSentencer_T11 | 1673-1852 | Sentence | denotes | Biochemical analysis indicated that reduced activity was the result not of post-translational modifications or allosteric changes, but instead of a low-molecular-weight inhibitor. |
TextSentencer_T12 | 1853-1988 | Sentence | denotes | After we adjusted for age and total prostate-specific antigen, reduced DPP4 activity remained a significant predictor of cancer status. |
TextSentencer_T13 | 1989-2270 | Sentence | denotes | The results of this proof-of-principle study suggest that DPP4 activity might be a potential blood-based indicator of the presence of metastatic cancer of prostatic origin, either by itself or, more likely, as a means to improve the sensitivity and specificity of existing markers. |
T1 | 0-102 | Sentence | denotes | Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. |
T2 | 103-190 | Sentence | denotes | Cancer is responsible for many deaths and is a major source of healthcare expenditures. |
T3 | 191-340 | Sentence | denotes | The identification of new, non-invasive biomarkers might allow improvement of the direct diagnostic or prognostic ability of already available tools. |
T4 | 341-598 | Sentence | denotes | Here, we took the innovative approach of interrogating the activity of exopeptidases in the serum of cancer patients with the aim of establishing a distinction based on enzymatic function, instead of simple protein levels, as a means to biomarker discovery. |
T5 | 599-854 | Sentence | denotes | We first analyzed two well-characterized mouse models of prostate cancer, each with a distinct genetic lesion, and established that broad exopeptidase and targeted aminopeptidase activity tests reveal proteolytic changes associated with tumor development. |
T6 | 855-1084 | Sentence | denotes | We also describe new peptide-based freeze-frame reagents uniquely suited to probe the altered balance of selected aminopeptidases, as opposed to the full array of exopeptidases, and/or their modulators in patient serum or plasma. |
T7 | 1085-1205 | Sentence | denotes | One particular proteolytic activity was impaired in animals with aggressive disease relative to cancer-free littermates. |
T8 | 1206-1363 | Sentence | denotes | We identified the protease in question as dipeptidyl peptidase 4 (DPP4) by analyzing selected knockout mice and evaluating the effect of specific inhibitors. |
T9 | 1364-1515 | Sentence | denotes | DPP4 activity was also reduced in the sera of patients with metastatic prostate cancer relative to patients with localized disease or healthy controls. |
T10 | 1516-1672 | Sentence | denotes | However, no significant differences in DPP4 serum levels were observed, which established the loss of activity as the result of impaired enzymatic function. |
T11 | 1673-1852 | Sentence | denotes | Biochemical analysis indicated that reduced activity was the result not of post-translational modifications or allosteric changes, but instead of a low-molecular-weight inhibitor. |
T12 | 1853-1988 | Sentence | denotes | After we adjusted for age and total prostate-specific antigen, reduced DPP4 activity remained a significant predictor of cancer status. |
T13 | 1989-2270 | Sentence | denotes | The results of this proof-of-principle study suggest that DPP4 activity might be a potential blood-based indicator of the presence of metastatic cancer of prostatic origin, either by itself or, more likely, as a means to improve the sensitivity and specificity of existing markers. |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 433-438 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T2 | 1068-1073 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T3 | 1560-1565 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T4 | 2082-2087 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 433-438 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T2 | 1068-1073 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T3 | 1560-1565 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T4 | 2082-2087 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 86-101 | Phenotype | denotes | prostate cancer | HP:0012125 |
T2 | 103-109 | Phenotype | denotes | Cancer | HP:0002664 |
T3 | 442-448 | Phenotype | denotes | cancer | HP:0002664 |
T4 | 656-671 | Phenotype | denotes | prostate cancer | HP:0012125 |
T5 | 836-841 | Phenotype | denotes | tumor | HP:0002664 |
T6 | 1150-1160 | Phenotype | denotes | aggressive | HP:0000718 |
T7 | 1181-1187 | Phenotype | denotes | cancer | HP:0002664 |
T8 | 1435-1450 | Phenotype | denotes | prostate cancer | HP:0012125 |
T9 | 1974-1980 | Phenotype | denotes | cancer | HP:0002664 |
T10 | 2134-2140 | Phenotype | denotes | cancer | HP:0002664 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 75-101 | Disease | denotes | metastatic prostate cancer | http://purl.obolibrary.org/obo/MONDO_0004956 |
T2 | 103-109 | Disease | denotes | Cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T3 | 442-448 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T4 | 656-671 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T5 | 836-841 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T6 | 1181-1187 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T7 | 1424-1450 | Disease | denotes | metastatic prostate cancer | http://purl.obolibrary.org/obo/MONDO_0004956 |
T8 | 1974-1980 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T9 | 2123-2140 | Disease | denotes | metastatic cancer | http://purl.obolibrary.org/obo/MONDO_0024880 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 640-645 | OrganismTaxon | denotes | mouse | 10088|10090 |
T3 | 1060-1067 | OrganismTaxon | denotes | patient | 9606 |
T4 | 1309-1313 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 86-94 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T2 | 656-664 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T3 | 1077-1083 | Body_part | denotes | plasma | http://purl.obolibrary.org/obo/UBERON_0001969 |
T4 | 1435-1443 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T5 | 1889-1897 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T6 | 2082-2087 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 86-94 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T2 | 656-664 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T3 | 1435-1443 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T4 | 1889-1897 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T5 | 2082-2087 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
T7 | 2144-2153 | Body_part | denotes | prostatic | http://purl.obolibrary.org/obo/MAT_0000078 |